Status:
COMPLETED
Neuro-COVID-19: Neurological Complications of COVID-19
Lead Sponsor:
Emanuela Keller
Conditions:
Neurologic Complication
Eligibility:
All Genders
18+ years
Brief Summary
The prevalence and typical patterns of neurological complications in hospitalized COVID-19 patients admitted to the intensive care units of the University Hospital Zurich will be investigated. The imp...
Detailed Description
This study is a prospective observational cohort study to document prevalence and severity of neurological symptoms among patients requiring critical care admission for confirmed novel coronavirus dis...
Eligibility Criteria
Inclusion
- Adults (age \> 18 years old) treated at ICUs
- Admitted with confirmed COVID-19 infection
- Patient exhibiting acute neurological manifestations
- General consent of the Institute of Intensive Care Medicine available from patient or legal representative
Exclusion
- Pre-existing severe neurologic dysfunction
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 9 2022
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04418609
Start Date
May 1 2020
End Date
June 9 2022
Last Update
August 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich
Zurich, Switzerland, 8091